Stay updated with breaking news from Cullen Taniguchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new Phase Ib/II study from researchers at The University of Texas MD Anderson Cancer Center and Moffitt Cancer Center found that combining sensitizing drugs with a specific form of radiation therapy may be more effective in patients with locally advanced pancreatic cancer, yielding a higher progression-free survival (PFS) and overall response rate (ORR).
<p>A new Phase Ib/II study from researchers at <a href="https://www.mdanderson.org/">The University of Texas MD Anderson Cancer Center</a> and <a href="https://www.moffitt.org/">Moffitt Cancer Center</a> found that combining sensitizing drugs with a specific form of radiation therapy may be more effective in patients with locally advanced <a href="https://www.mdanderson.org/cancer-types/pancreatic-cancer.html">pancreatic cancer</a>, yielding a higher progression-free survival (PFS) and overall response rate (ORR)....
Cullen Taniguchi died on November 15, 2023, leaving the medical community and colleagues in mourning, the reason of his death unknown. Is Cullen Taniguchi Dead? Yes, Dr. Cullen Taniguchi has died. He was a well-known physician-scientist at the University of Texas MD Anderson Cancer Centre, best recognised for his work in cancer research, notably in […]
Cullen Taniguchi Death Reason? Associate Professor at the Esteemed UT MD Anderson Cancer Center Dies His sudden demise is a great loss that has deeply saddened